Surprisingly, in previous in vivo study, neither losartan nor PD123319 decreased the cellular proliferation in DES-induced PRL-secreting tumor in rat, although it was inhibited by angiotensin convertase inhibitor, enalaprilate [28]. The gene discussed is PRL; the disease is neoplasm.